The cures are coming.
For self-insured employers & health plans
Cell and gene therapies can change lives. But a single claim can reach into the millions.
Aradigm helps you prepare—with a predictable way to cover these treatments and support member access.
Aradigm is a public benefit corporation built to expand access to cell and gene therapies and make them more affordable.
Get the overview
See how Aradigm helps plans manage cell and gene therapy costs and support access. Two pages. A clear place to start.
Extraordinary science. A practical way to cover it.
The challenge
Cell and gene therapies offer new possibilities for members. Their high costs and unpredictable timing can put pressure on a plan’s budget.
The Aradigm approach
A specialty coverage program that brings together shared financial risk and care support for cell and gene therapies.
What it means for you
A predictable per-member, per-month cost, with access to covered therapies through a network of qualified providers.